Copyright Reports & Markets. All rights reserved.

Global Sustained Release Injectables Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Sustained Release Injectables Market Status and Forecast (2017-2028)
      • 1.3.2 Global Sustained Release Injectables Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Sustained Release Injectables Supply by Company

    • 2.1 Global Sustained Release Injectables Sales Volume by Company
    • 2.2 Global Sustained Release Injectables Sales Value by Company
    • 2.3 Global Sustained Release Injectables Price by Company
    • 2.4 Sustained Release Injectables Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Sustained Release Injectables Market Status by Type

    • 3.1 Sustained Release Injectables Type Introduction
      • 3.1.1 Naltrexone
      • 3.1.2 Exenatide
      • 3.1.3 Estradiol
      • 3.1.4 Other
    • 3.2 Global Sustained Release Injectables Market by Type
      • 3.2.1 Global Sustained Release Injectables Sales Volume by Type (2017-2022)
      • 3.2.2 Global Sustained Release Injectables Sales Value by Type (2017-2022)
      • 3.2.3 Global Sustained Release Injectables Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Sustained Release Injectables Market Status by Application

    • 4.1 Sustained Release Injectables Segment by Application
      • 4.1.1 Diabetes
      • 4.1.2 Leukemia
      • 4.1.3 Acromegaly
      • 4.1.4 Other
    • 4.2 Global Sustained Release Injectables Market by Application
      • 4.2.1 Global Sustained Release Injectables Sales Volume by Application (2017-2022)
      • 4.2.2 Global Sustained Release Injectables Sales Value by Application (2017-2022)
      • 4.2.3 Global Sustained Release Injectables Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Sustained Release Injectables Market Status by Region

    • 5.1 Global Sustained Release Injectables Market by Region
      • 5.1.1 Global Sustained Release Injectables Sales Volume by Region
      • 5.1.2 Global Sustained Release Injectables Sales Value by Region
    • 5.2 North America Sustained Release Injectables Market Status
    • 5.3 Europe Sustained Release Injectables Market Status
    • 5.4 Asia Pacific Sustained Release Injectables Market Status
    • 5.5 Central & South America Sustained Release Injectables Market Status
    • 5.6 Middle East & Africa Sustained Release Injectables Market Status

    6 North America Sustained Release Injectables Market Status

    • 6.1 North America Sustained Release Injectables Market by Country
      • 6.1.1 North America Sustained Release Injectables Sales Volume by Country (2017-2022)
      • 6.1.2 North America Sustained Release Injectables Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Sustained Release Injectables Market Status

    • 7.1 Europe Sustained Release Injectables Market by Country
      • 7.1.1 Europe Sustained Release Injectables Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Sustained Release Injectables Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Sustained Release Injectables Market Status

    • 8.1 Asia Pacific Sustained Release Injectables Market by Country
      • 8.1.1 Asia Pacific Sustained Release Injectables Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Sustained Release Injectables Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Sustained Release Injectables Market Status

    • 9.1 Central & South America Sustained Release Injectables Market by Country
      • 9.1.1 Central & South America Sustained Release Injectables Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Sustained Release Injectables Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Sustained Release Injectables Market Status

    • 10.1 Middle East & Africa Sustained Release Injectables Market by Country
      • 10.1.1 Middle East & Africa Sustained Release Injectables Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Sustained Release Injectables Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Sustained Release Injectables Manufacturing Cost Analysis
    • 11.5 Sustained Release Injectables Sales Channel and Distributors Analysis
      • 11.5.1 Sustained Release Injectables Sales Channel
      • 11.5.2 Sustained Release Injectables Distributors
    • 11.6 Sustained Release Injectables Downstream Major Buyers

    12 Global Sustained Release Injectables Market Forecast by Type and by Application

    • 12.1 Global Sustained Release Injectables Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Sustained Release Injectables Forecast by Type
      • 12.2.1 Global Sustained Release Injectables Sales Volume Forecast by Type
      • 12.2.2 Global Sustained Release Injectables Sales Value Forecast by Type
      • 12.2.3 Global Sustained Release Injectables Price Forecast by Type
    • 12.3 Global Sustained Release Injectables Forecast by Application
      • 12.3.1 Global Sustained Release Injectables Sales Volume Forecast by Application
      • 12.3.2 Global Sustained Release Injectables Sales Value Forecast by Application
      • 12.3.3 Global Sustained Release Injectables Price Forecast by Application

    13 Global Sustained Release Injectables Market Forecast by Region/Country

    • 13.1 Global Sustained Release Injectables Market Forecast by Region (2023-2028)
      • 13.1.1 Global Sustained Release Injectables Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Sustained Release Injectables Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Taiwan Liposome Company
      • 14.1.1 Company Information
      • 14.1.2 Sustained Release Injectables Product Introduction
      • 14.1.3 Taiwan Liposome Company Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Sanofi
      • 14.2.1 Company Information
      • 14.2.2 Sustained Release Injectables Product Introduction
      • 14.2.3 Sanofi Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Roche
      • 14.3.1 Company Information
      • 14.3.2 Sustained Release Injectables Product Introduction
      • 14.3.3 Roche Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Novartis
      • 14.4.1 Company Information
      • 14.4.2 Sustained Release Injectables Product Introduction
      • 14.4.3 Novartis Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Eli Lilly
      • 14.5.1 Company Information
      • 14.5.2 Sustained Release Injectables Product Introduction
      • 14.5.3 Eli Lilly Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Critical Pharmaceuticals
      • 14.6.1 Company Information
      • 14.6.2 Sustained Release Injectables Product Introduction
      • 14.6.3 Critical Pharmaceuticals Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Camurus
      • 14.7.1 Company Information
      • 14.7.2 Sustained Release Injectables Product Introduction
      • 14.7.3 Camurus Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Biomarin
      • 14.8.1 Company Information
      • 14.8.2 Sustained Release Injectables Product Introduction
      • 14.8.3 Biomarin Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Avadel
      • 14.9.1 Company Information
      • 14.9.2 Sustained Release Injectables Product Introduction
      • 14.9.3 Avadel Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Aurobindo
      • 14.10.1 Company Information
      • 14.10.2 Sustained Release Injectables Product Introduction
      • 14.10.3 Aurobindo Sustained Release Injectables Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 AstraZeneca
    • 14.12 Ascendis Pharma
    • 14.13 Amylin
    • 14.14 Alkermes

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Sustained Release Injectables market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Sustained Release Injectables industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Sustained Release Injectables market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Sustained Release Injectables Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Sustained Release Injectables market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Sustained Release Injectables Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Sustained Release Injectables industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Naltrexone
      Exenatide

      Segmented by Application
      Diabetes
      Leukemia
      Acromegaly
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Roche
      Novartis
      Eli Lilly
      Critical Pharmaceuticals
      Camurus
      Biomarin
      Avadel
      Aurobindo
      AstraZeneca
      Ascendis Pharma
      Amylin
      Alkermes
      Buy now